SCHEMBL5365217

SCHEMBL5365217

COCCOCc1c(C)n(Cc2ccc(F)cc2F)c2cnc(C(=O)O)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 3/20 0.41
PTGDR2 Q9Y5Y4 10/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C8 P10632 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2A6 P11509 1/20 0.41
CYP2B6 P20813 1/20 0.41
PTGDR Q13258 1/20 0.41
PPARG P37231 1/20 0.37
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5372921 0.99 PTGDR2 (0.41) PTGER1PTGDR2CYP1A2CYP3A4CYP2C9
SCHEMBL4805917 0.82 PTGER1 (0.40) PTGER1PTGDR2CYP2C19PPARGMEN1
SCHEMBL2948464 0.76 F2RL3 (0.41) PTGER1PTGDR2CYP1A2CYP3A4CYP2C9
SCHEMBL4808924 0.75 PTGER1 (0.42) PTGER1PTGDR2CYP1A2CYP3A4CYP2C9
SCHEMBL4804162 0.74 FSCN1 (0.40) PTGDR2PPARGMEN1KMT2A
SCHEMBL4803688 0.73 FSCN1 (0.39) PTGDR2PPARGMEN1KMT2A
SCHEMBL4805488 0.73 FSCN1 (0.39) PTGDR2PPARGMEN1KMT2A
SCHEMBL4804543 0.73 FSCN1 (0.39) PTGDR2PPARGMEN1KMT2A
SCHEMBL4804042 0.73 FSCN1 (0.37) PTGER1PTGDR2CYP2C19PPARGMEN1
SCHEMBL4806883 0.72 MMP13 (0.42) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756103-A2 PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS HIV-INTEGRASE INHIBITORS Pfizer, Inc. (US) 2007-02-28 EP disclosed
WO-2005103003-A2 PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS HIV-INTEGRASE INHIBITORS PFIZER INC. (US) 2005-11-03 WO disclosed